These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8843056)

  • 1. DNA ploidy, S-phase, and Ki-67 antigen expression in the evaluation of cell content of pleural effusions.
    Sikora J; Dworacki G; Zeromski J
    Lung; 1996; 174(5):303-13. PubMed ID: 8843056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of nucleolar organiser regions and DNA flow cytometry in the evaluation of pleural effusion.
    Huang MS; Tsai MS; Hwang JJ; Wang TH
    Thorax; 1994 Nov; 49(11):1152-6. PubMed ID: 7831633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between DNA content, expression of Ki-67 antigen of tumor cells and immunophenotype of lymphocytes from malignant pleural effusions.
    Sikora J; Dworacki G; Trybus M; Batura-Gabryel H; Zeromski J
    Tumour Biol; 1998; 19(3):196-204. PubMed ID: 9591046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparameter flow cytometric DNA analysis of effusions: a prospective study of 36 cases compared with routine cytology and immunohistochemistry.
    Joseph MG; Banerjee D; Harris P; Gibson S; McFadden RG
    Mod Pathol; 1995 Aug; 8(6):686-93. PubMed ID: 8532707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic value of DNA, RNA and proliferating cell nuclear antigen examination in malignant pleural effusions by flow cytometry].
    Wang LX; Chen WX; Wu J; Chen SX; Huang XY; Chen YF
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Dec; 29(12):804-7. PubMed ID: 17327081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric DNA ploidy and S-phase heterogeneity in advanced ovarian carcinoma.
    Kaern J; Tropé CG; Kristensen GB; Pettersen EO
    Cancer; 1994 Apr; 73(7):1870-7. PubMed ID: 8137213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interphase nucleolar organizer regions in the evaluation of serosal cavity effusions.
    Carrillo R; Sneige N; el-Naggar AK
    Acta Cytol; 1994; 38(3):367-72. PubMed ID: 8191825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of DNA ploidy and S-phase fraction in fine needle aspirates from breast carcinoma.
    Panwar S; Handa U; Kaur M; Mohan H; Attri AK
    Diagn Cytopathol; 2021 Jun; 49(6):761-767. PubMed ID: 33755349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic comparative study of S-phase fraction and Ki-67 index in breast carcinoma.
    Pinto AE; André S; Pereira T; Nóbrega S; Soares J
    J Clin Pathol; 2001 Jul; 54(7):543-9. PubMed ID: 11429427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of pleural effusions using flow cytometry.
    Ceyhan BB; Demiralp E; Celikel T
    Respiration; 1996; 63(1):17-24. PubMed ID: 8833988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric analysis of DNA content and Ki-67-positive fractions in the diagnosis of salivary gland tumors.
    Horii A; Yoshida J; Sakai M; Okamoto S; Kubo T
    Eur Arch Otorhinolaryngol; 1998; 255(5):265-8. PubMed ID: 9638470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric DNA analysis of pleural effusions.
    Huang MS; Tsai MS; Wang TH; Lin MS; Chong IW; Chen KL; Hwang JJ
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Dec; 8(12):640-6. PubMed ID: 1296045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of pleural effusions by flow-cytometric DNA analysis.
    Høstmark J; Vigander T; Skaarland E
    Eur J Respir Dis; 1985 May; 66(5):315-9. PubMed ID: 4018184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT; Gentile P; Tarectecan A; Fuchs A
    Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction.
    Nordström B; Strang P; Bergström R; Nilsson S; Tribukait B
    Cancer; 1996 Nov; 78(9):1942-51. PubMed ID: 8909315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma.
    Victorzon M; Roberts PJ; Haglund C; von Boguslawsky K; Nordling S
    Oncology; 1996; 53(3):182-91. PubMed ID: 8643219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-tube triple staining method for flow cytometric analysis of DNA ploidy and phenotypic heterogeneity of human solid tumors using single laser excitation.
    Corver WE; Bonsing BA; Abeln EC; Vlak-Theil PM; Cornelisse CJ; Fleuren GJ
    Cytometry; 1996 Dec; 25(4):358-66. PubMed ID: 8946143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
    Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P
    Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of ploidy in immunohistochemically confirmed examples of malignant epithelial mesothelioma.
    Frierson HF; Mills SE; Legier JF
    Am J Clin Pathol; 1988 Sep; 90(3):240-3. PubMed ID: 3414598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.